Publications Database

McCracken J. T. (2005)

Safety issues with drug therapies for autism spectrum disorders.

Journal of Clinical Psychiatry

66 pp. 32-37

Read Abstract (New Window)

McGee W. (2007)

Vitamin C.

Bethesda, MD: U.S. National Library of Medicine

Read Full (New Window)

McLay L. K. , France K. (2016)

Empirical research evaluating non-traditional approaches to managing sleep problems in children with autism.

Developmental Neurorehabilitation

April, 19(2), pp.123-134.

Read Abstract (New Window)

National Center for Complementary and Alternative Medicine (2007)

An introduction to probiotics.

Bethesda, MD: National Center for Complementary and Alternative Medicine

Read Full (New Window)

Megson M. N. (1999)

Is autism A G-Alpha protein defect reversible with nautural vitamin A?

Richmond, VA: Mary N. Megson

Read Full (New Window)

Meguid N. A. et al. (2008)

Role of polyunsaturated fatty acids in the management of Egyptian children with autism.

Clinical Biochemistry

Read Abstract (New Window)

Mehl-Madrona L. (2000)

Effective therapies for autism and other developmental disorders.

Autism/Asperger's Digest Magazine

Mehl-Madrona L. et al. (2010)

Micronutrients versus standard medication management in autism: A naturalistic case-control study.

Journal of Child and Adolescent Psychopharmacology

20(2), pp. 95-103.

Read Abstract (New Window) Read Full (New Window)

Meiri G. , Bichovsky Y. , Belmaker R. (2009)

Omega 3 fatty acid treatment in autism.

Journal of Child and Adolescent Psychopharmacology

19(4), pp. 449-451

Read Abstract (New Window)

Memorial Sloan Kettering Cancer Center (2016)

Zeolite.

New York: NY: Memorial Sloan Kettering Cancer Center

Read Full (New Window)

Memorial Sloan-Kettering Cancer Center (2011)

Dimethylglycine.

New York, NY: Memorial Sloan Kettering Cancer Center

Read Full (New Window)

Menage P. et al. (1992)

CD4+ CD45RA+ T lymphocyte deficiency in autistic children: effect of a pyridoxine-magnesium treatment.

Brain Dysfunction

5(5), pp. 326-333

Millward C. et al. (2008)

Gluten- and casein-free diets for autistic spectrum disorder.

Cochrane Database of Systematic Reviews

April, 16(2), CD003498

Read Abstract (New Window) Read Full (New Window)

Mire S. S. et al.

Parent perceptions about autism spectrum disorder influence treatment choices.

Focus on Autism and Other Developmental Disabilities

Read Abstract (New Window)

Miyaoka T. et al. (2012)

Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study.

BMC Psychiatry

12 pp. 215.

Read Abstract (New Window) Read Full (New Window)

Moss N. , Boverman H. (1978)

Megavitamin therapy for autistic children.

American Journal of Psychiatry

135(11), pp. 1425-1426

Mousain-Bosc M. et al. (2006)

Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism.

Magnesium Research

19(1), pp. 53-62.

Read Abstract (New Window) Read Full (New Window)

Mulloy A. et al. (2011)

Addendum to 'gluten-free and casein-free diets in treatment of autism spectrum disorders: A systematic review'

Research in Autism Spectrum Disorders

5(1), pp. 86-88

Read Abstract (New Window)

Mulloy A. et al. (2010)

Gluten-free and casein-free diets in the treatment of autism spectrum disorders: A systematic review.

Research in Autism Spectrum Disorders

4(3), pp. 328-339

Read Abstract (New Window)

Munasinghe S. et al. (2010)

Digestive enzyme supplementation for autism spectrum disorders: A double-blind randomized controlled trial.

Journal of Autism and Developmental Disorders

40(9), pp. 1131-1138

Read Abstract (New Window)